España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Enlivex Therapeutics
ENLV
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.929300
0.09
10.50%
At close: -
$0.899900
-0.03
-3.16%
After Hours: 9:22 AM EDT
Get Report
Comment
Enlivex Therapeutics (ENLV) Forecast
News
Earnings
Enlivex Therapeutics (ENLV) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Enlivex Therapeutics (NASDAQ:ENLV) Stock
Enlivex Therapeutics Stock (NASDAQ: ENLV)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 20, 2024
Enlivex Therapeutics shares are trading highe...
Benzinga Newsdesk
Enlivex Board Approves Purchase Of Up To $1M ...
Benzinga Newsdesk
Thursday, November 14, 2024
D. Boral Capital Maintains Buy on Enlivex The...
Benzinga Newsdesk
Enlivex Announces The Dosing Of The First Pat...
Benzinga Newsdesk
Tuesday, November 12, 2024
Enlivex Announces Enrollment And Dosing Of Fi...
Benzinga Newsdesk
Wednesday, October 30, 2024
Enlivex Receives Notice Of Allowance For Japa...
Benzinga Newsdesk
Friday, September 27, 2024
HC Wainwright & Co. Reiterates Buy on Enlivex...
Benzinga Newsdesk
Thursday, September 26, 2024
EF Hutton Maintains Buy on Enlivex Therapeuti...
Benzinga Newsdesk
Enlivex Receives Approval From Danish Medicin...
Benzinga Newsdesk
Tuesday, September 24, 2024
EF Hutton Maintains Buy on Enlivex Therapeuti...
Benzinga Newsdesk
Enlivex Receives DSMB Recommendation To Proce...
Benzinga Newsdesk
Monday, September 09, 2024
HC Wainwright & Co. Reiterates Buy on Enlivex...
Benzinga Newsdesk
Tuesday, August 27, 2024
EF Hutton Initiates Coverage On Enlivex Thera...
Benzinga Newsdesk
Tuesday, July 23, 2024
Enlivex Receives Israeli Ministry Of Health A...
Benzinga Newsdesk
Monday, June 24, 2024
Enlivex Doses First Patient In A Randomized, ...
Benzinga Newsdesk
Monday, June 17, 2024
Enlivex Therapeutics Releases Interim Data Re...
Benzinga Newsdesk
Tuesday, June 11, 2024
HC Wainwright & Co. Maintains Buy on Enlivex ...
Benzinga Newsdesk
Monday, June 03, 2024
Enlivex Receives Regulatory Authorization For...
Benzinga Newsdesk
Tuesday, May 28, 2024
Enlivex Therapeutics Enters Agreement For Reg...
Benzinga Newsdesk
Monday, April 29, 2024
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Tuesday, April 23, 2024
HC Wainwright & Co. Reiterates Buy on Enlivex...
Benzinga Newsdesk
Monday, April 22, 2024
Enlivex Announces Dosing Of First Two Patient...
Benzinga Newsdesk
Tuesday, April 16, 2024
Enlivex Announces Authorization From Danish M...
Benzinga Newsdesk
Friday, April 12, 2024
Tesla To $180? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Enlivex ...
Benzinga Newsdesk
Thursday, April 11, 2024
Nasdaq Jumps 250 Points; Crude Oil Down 1%
Avi Kapoor
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Dow Dips 100 Points; CarMax Earnings Miss Views
Avi Kapoor
Nasdaq Gains Over 50 Points; US Producer Prices Increase In March
Avi Kapoor
Enlivex shares are trading lower. The company...
Benzinga Newsdesk
Enlivex Announces Topline Results Of Its Phas...
Benzinga Newsdesk
Monday, February 26, 2024
Enlivex Receives Regulatory Authorization Fro...
Benzinga Newsdesk
Wednesday, February 21, 2024
Enlivex Completes Enrollment Of 120 Patients ...
Benzinga Newsdesk
Wednesday, February 07, 2024
Enlivex Announces Issuance Of New U.S. Patent...
Benzinga Newsdesk
Wednesday, January 17, 2024
Enlivex Receives IMOH Authorization For Initi...
Benzinga Newsdesk
Tuesday, December 26, 2023
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Friday, December 22, 2023
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Wednesday, December 20, 2023
Enlivex Therapeutics shares are trading highe...
Benzinga Newsdesk
Enlivex Therapeutics Announced That The Comp...
Benzinga Newsdesk
Friday, November 03, 2023
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Monday, September 25, 2023
HC Wainwright & Co. Maintains Buy on Enlivex ...
Benzinga Newsdesk
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Friday, September 15, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, September 11, 2023
Enlivex Therapeutics H1 Research And Developm...
Benzinga Newsdesk
Enlivex Therapeutics Intends To Reduce Its Wo...
Bill Haddad
Tuesday, August 08, 2023
Enlivex Therapeutics Granted U.S. Patent #11717539: Combination Immune Therapy And Cytokine Control Therapy For Cancer Treatment
Charles Gross
Wednesday, August 02, 2023
Enlivex Announces Peer-Reviewed Publication In Frontiers In Immunology Of Clinical Data Details Resolution Of Acute Respiratory Distress Syndrome From Two Phase I/II Trials Evaluating Allocetra In Patients With COVID-19
Happy Mohamed
Tuesday, August 01, 2023
HC Wainwright & Co. Reiterates Buy on Enlivex...
Benzinga Newsdesk
Monday, July 31, 2023
Enlivex Announces Dosing Of First Patient Under The Amended Protocol Of Its Phase II trial Evaluating Allocetra In Patients With Sepsis
Happy Mohamed
Monday, June 26, 2023
CORRECTION: Enlivex Therapeutics Reports Q1 N...
Benzinga Newsdesk
Show More